Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$2.5B |
| 2 |
Apple
AAPL
|
+$1.68B |
| 3 |
Tesla
TSLA
|
+$951M |
| 4 |
Johnson & Johnson
JNJ
|
+$750M |
| 5 |
UnitedHealth
UNH
|
+$703M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CTXS
Citrix Systems Inc
CTXS
|
+$913M |
| 2 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$257M |
| 3 |
NVIDIA
NVDA
|
+$225M |
| 4 |
Vertiv
VRT
|
+$164M |
| 5 |
JPMorgan Chase
JPM
|
+$161M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 12.48% |
| 2 | Healthcare | 7.36% |
| 3 | Financials | 6.5% |
| 4 | Consumer Discretionary | 5.35% |
| 5 | Industrials | 3.62% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2201
HealthEquity
HQY
$8.79B
| $2.05M | ﹤0.01% |
33,318
+13,465
| +68% | +$905K |
|
2202
Myriad Genetics
MYGN
$311M
| $2.05M | ﹤0.01% |
141,447
+7,203
| +5% | +$134K |
|
2203
PUT
Yum! Brands
YUM
$41.2B
| $2.05M | ﹤0.01% |
+16,000
| New | +$1.94M |
|
2204
Brookfield Infrastructure
BIPC
$4.81B
| $2.05M | ﹤0.01% |
52,670
+11,711
| +29% | +$497K |
|
2205
MaxLinear
MXL
$6.86B
| $2.05M | ﹤0.01% |
60,346
+7,872
| +15% | +$267K |
|
2206
Vanguard FTSE Developed Markets ETF
VEA
$236B
| $2.04M | ﹤0.01% |
48,720
+440
| +0.9% | +$17.8K |
|
|
CS
2207
DELISTED
Credit Suisse Group
CS
| $2.04M | ﹤0.01% |
672,428
+304,385
| +83% | +$1.18M |
|
2208
Compass Minerals
CMP
$1.16B
| $2.04M | ﹤0.01% |
49,731
+40,694
| +450% | +$1.68M |
|
2209
FIGS
FIGS
$2.42B
| $2.03M | ﹤0.01% |
301,653
+160,721
| +114% | +$1.16M |
|
2210
Prestige Consumer Healthcare
PBH
$2.62B
| $2.03M | ﹤0.01% |
32,364
+7,358
| +29% | +$422K |
|
|
TLGY
2211
DELISTED
TLGY Acquisition Corporation Class A Ordinary Share
TLGY
| $2.02M | ﹤0.01% |
197,210
| – | – |
|
2212
Nexstar Media Group
NXST
$5.98B
| $2.02M | ﹤0.01% |
11,552
-13,699
| -54% | -$2.4M |
|
2213
Houlihan Lokey
HLI
$9.02B
| $2.01M | ﹤0.01% |
23,060
+6,320
| +38% | +$568K |
|
|
AIMC
2214
DELISTED
Altra Industrial Motion Corp
AIMC
| $2.01M | ﹤0.01% |
33,612
-1,328
| -4% | -$69.7K |
|
2215
FNB Corp
FNB
$6.76B
| $2.01M | ﹤0.01% |
153,647
+37,716
| +33% | +$505K |
|
2216
Bausch Health
BHC
$2.3B
| $2M | ﹤0.01% |
318,751
-666,550
| -68% | -$4.66M |
|
2217
Peabody Energy
BTU
$2.89B
| $2M | ﹤0.01% |
75,667
-125,439
| -62% | -$3.45M |
|
2218
iShares MSCI China ETF
MCHI
$6.37B
| $2M | ﹤0.01% |
42,071
-19,745
| -32% | -$856K |
|
2219
Jones Lang LaSalle
JLL
$16.7B
| $2M | ﹤0.01% |
12,524
-1,278
| -9% | -$204K |
|
2220
Federal Signal
FSS
$7.89B
| $1.99M | ﹤0.01% |
42,923
+26,844
| +167% | +$1.23M |
|
2221
Lithia Motors
LAD
$8.24B
| $1.99M | ﹤0.01% |
9,708
-3,765
| -28% | -$805K |
|
2222
First Bancorp
FBP
$4.4B
| $1.99M | ﹤0.01% |
156,092
+59,026
| +61% | +$861K |
|
2223
Diodes
DIOD
$4.83B
| $1.98M | ﹤0.01% |
26,052
+6,783
| +35% | +$531K |
|
|
WEL
2224
DELISTED
Integrated Wellness Acquisition Corp
WEL
| $1.98M | ﹤0.01% |
192,909
| – | – |
|
2225
Camping World
CWH
$654M
| $1.98M | ﹤0.01% |
88,802
+39,829
| +81% | +$1.03M |
|
Similar funds
Barclays's Q4 2022 Portfolio in Review
As of Q4 2022, Barclays held 5,646 positions worth $223B, up 144% from $91.6B the previous quarter. Its ten largest holdings account for 41% of the portfolio.
Barclays deployed $128B of net new capital in Q4 2022, opening 797 new positions and adding to 2,634 existing holdings. Its largest new stake was Seadrill: 1,546,558 shares worth $50.5M.
By sector, the portfolio is most concentrated in Technology at 12% of assets, down from 23% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Horizon Therapeutics Public Limited Company Ordinary Shares, an estimated $257M trimmed.
- Barclays's largest Q4 2022 buy was Seadrill: 1,546,558 shares worth $50.5M.
- Barclays added most to Microsoft in Q4 2022, an estimated $2.5B increase.
- Barclays's biggest Q4 2022 reduction was Horizon Therapeutics Public Limited Company Ordinary Shares, cutting an estimated $257M.
- Barclays fully exited Citrix Systems Inc in Q4 2022, selling an estimated $913M.
- Barclays's ten largest holdings make up 41% of its $223B portfolio in Q4 2022.
- Barclays opened 797 new positions and closed 385 in Q4 2022.
- Barclays's portfolio value rose 144% quarter-over-quarter to $223B.
Based on Barclays's 13F filing for Q4 2022, filed 13 Feb 2023.